Table S5 from Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2− Breast Cancer

Key Points

• Endocrine therapy pathways demonstrate distinct resistant and responsive modules, highlighting treatment variability.
• Precision treatment techniques refine traditional therapy methods used for HR+/HER2− breast cancer, indicating personalized approaches.
• The findings are based on a structural analysis of the resistant pathways analyzed in Figure 4, emphasizing treatment outcomes.
• Data-driven decisions may enable more effective management of breast cancer, moving beyond one-size-fits-all strategies.